Search Results

Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting G

They are G-protein-coupled receptors and bind as ligand retinal, which is bound covalently to a lysine

Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled

August 2022 "Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors

August 2022 "G-protein-coupled receptors (GPCR) are present at the cell surface in different conformational

A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent

Hexahydroquinoline Derivatives are Selective Agonists for the Adhesion G Protein-Coupled Receptor ADGRG1 The G protein-coupled receptor neuropeptide receptor-15 modulates larval development via the transforming

Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G

to 20, 2023 Adhesion GPCRs Amelioration of non-alcoholic fatty liver disease by targeting adhesion G that a glucagon-bound extracellular domain of the glucagon receptor is dynamic Ligand recognition and G

. 30, 2021 -- Orion Biotechnology, a clinical stage company unlocking the therapeutic potential of G

gives me great pleasure to announce the fourth hybrid symposium on regulatory autoantibodies targeting G-protein-coupled

Enabling the Design of Nucleoside Functional Switches for the A2A Adenosine Receptor "Modulators of the G

regulation of gluconeogenic gene transcription is endocytosis-dependent in primary hepatocytes "A number of G

meningitidis and identified 30 N-acyl amides with representative members serving as agonists of the G-protein

October 2022 "The very large G protein-coupled receptor (VLGR1, ADGRV1) is the largest member of the

platform, which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G

recruitment, activation, and scaffolding of numerous cytoplasmic signaling complexes and assist in G-protein

coupling to the same GPCR in living cells "β-arrestins mediate regulatory processes for over 800 different G

non-nutritive sweetener sucralose increases β-arrestin signaling at the constitutively active orphan G complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency G

ligand may appear to bind with very high affinity when it facilitates formation of ligand-receptor-G

G protein-coupled receptors (GPCRs) are integral to cellular signaling, influencing a wide array of physiological

high-throughput drug screening, drug efficacy analyses, and toxicity studies; technologies that stabilize G

Opioid receptors are G-protein-coupled receptors (GPCRs) part of cell signaling paths of direct interest

Receptor-activity-modifying proteins (RAMPs) are ubiquitously expressed membrane proteins that associate with different G

4,5-bisphosphate (PI(4,5)P2) lipids have been shown to stabilize an active conformation of class A G-protein

Besides G-proteins and β-arrestins, 14-3-3 proteins participate in GPCR trafficking and signaling, and

antagonist and agonist ligands "The CX3C chemokine receptor 1 (CX3CR1), a member of the class A of G

synaptic modulation by α2-adrenergic receptors in auditory neurons GPCRs in Oncology and Immunology G and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein

recruitment, activation, and scaffolding of numerous cytoplasmic signaling complexes and assist in G-protein

Loss of biased signaling at a G protein-coupled receptor in overexpressed systems. Methods & Updates in GPCR Research The application of targeted protein degradation technologies to G